Tuberculosis in UK prisoners: A challenge for control

Journal of Epidemiology and Community Health

Volumn 64, Issue 4, 2010, Pages 373-376

  Anderson, Charlotte ^a   Story, Alistair ^a   Brown, Tim ^b   Drobniewski, Francis ^b   Abubakar, Ibrahim ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b HPA National Mycobacterium Reference Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

DRUG; DRUG RESISTANCE; HEALTH MONITORING; HEALTH POLICY; HEALTH RISK; HEALTH SERVICES; RISK FACTOR; SURVIVAL; TUBERCULOSIS;

ARTICLE; HUMAN; LUNG TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; PRISONER; STATISTICS; TUBERCULOSIS; UNITED KINGDOM;

ANTITUBERCULAR AGENTS; GREAT BRITAIN; HUMANS; ISONIAZID; PRISONERS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

UNITED KINGDOM;

EID: 77950202466     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2009.094375     Document Type: Article

References (19)

1. Anderson C, Moore J, Kruijshaar M, et al. Tuberculosis in the UK: annual report: on tuberculosis surveillance in the UK2008. London: Health Protection Agency Centre for Infections, 2008. http://www.hpa.org.uk/web/HPAwebFile/HPAweb- C/1225268885463.
2. Story A, Murad S, Roberts W, et al. Tuberculosis in London-the importance of homelessness, problem drug use and prison. Thorax 2007; 62: 667-671
3. Centers for Disease Control and Prevention (CDC), National Center for HIV/ AIDS, Viral Hepatitis, STD, and TB Prevention. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association. MMWR Recomm Rep 2006; 55(RR-9: 1-44.
4. Drobniewski FA. Tuberculosis in prisons- forgotten plague. Lancet 1995; 346: 948-949
5. Drobniewski FA, Balabanova Y, Ruddy M, et al. Tuberculosis, HIV seroprevalence, and intravenous drug abuse in Russian prisoners. Eur Respir J 2005; 26: 298-304.
6. Hanau-Bercot B, Gremy I, Raskine L, et al. A one year prospective study [1994-1995] for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis 2000; 4: 853-859
7. March F, Coll P, Guerrero RA, et al. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS 2000; 14: 525-535
8. Carbonara S, Babudieri S, Longo B, et al. Correlates of Mycobacterium tuberculosis infection in a prison population. Eur Respir J 2005; 25: 1070-1076
9. Prison Reform Trust. Prison factfile, 2005. http:/www.prisonreformtrust. org.uk (accessed Nov 2008).
10. Weild AR, Gill ON, Bennett D, et al. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health 2000; 3: 121-126
11. Ahmed S, Newton A, Allison T. Tuberculosis in a Yorkshire prison: case report. Euro Surveil 2007; 12: 242-245 http://Vwww.eurosurveillance.org/em/ v12n09/1209-227.asp (accessed Nov 2008).
12. Ruddy MC, Davies AP, Yates MD, et al. Outbreak of isoniazid resistant tuberculosis in north London. Thorax 2004; 59: 279-285
13. Gibson A, Brown T, Drobniewski F. Can 15-locus Mycobacterial interspersed repetitive unit-variable-number tandem repeat analysis provide insight into the evolution of Mycobacterium tuberculosis? Appl Environ Microbiol 2005; 71: 8207-8213
14. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco-a population-cased study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709
15. Kim S, Crittenden K. Treatment completion among TB patients returned to the community from a large urban jail. J Community Health 2007; 32: 135-147
16. Marco A, Cayla JA, Serra M, et al. Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Eur Respir J 1998; 12: 967-971
17. Levy MH, Butler TG, Zhou J. Prevalence of Mantoux positivity and annual risk of infection for tuberculosis in New South Wales prisoners, 1996-2001. N S W Public Health Bull 2007; 18: 119-124.
18. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians, 2006.
19. Jones TF, Schaffner W. Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis. Am J Respir Crit Care Med 2001; 164: 77-81.